705 related articles for article (PubMed ID: 10572324)
21. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
Schatzberg A; Roose S
Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
[TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
Suri RA; Altshuler LL; Rasgon NL; Calcagno JL; Frye MA; Gitlin MJ; Hwang S; Zuckerbrow-Miller J
J Clin Psychiatry; 2000 Dec; 61(12):942-6. PubMed ID: 11206600
[TBL] [Abstract][Full Text] [Related]
24. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
Schmidt ME; Fava M; Robinson JM; Judge R
J Clin Psychiatry; 2000 Nov; 61(11):851-7. PubMed ID: 11105738
[TBL] [Abstract][Full Text] [Related]
26. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
27. Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
Mowla A; Kardeh E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):970-3. PubMed ID: 21291943
[TBL] [Abstract][Full Text] [Related]
28. Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison.
Dalery J; Honig A
Hum Psychopharmacol; 2003 Jul; 18(5):379-84. PubMed ID: 12858325
[TBL] [Abstract][Full Text] [Related]
29. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
[TBL] [Abstract][Full Text] [Related]
30. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
Kasper S; Hajak G; Wulff K; Hoogendijk WJ; Montejo AL; Smeraldi E; Rybakowski JK; Quera-Salva MA; Wirz-Justice AM; Picarel-Blanchot F; Baylé FJ
J Clin Psychiatry; 2010 Feb; 71(2):109-20. PubMed ID: 20193645
[TBL] [Abstract][Full Text] [Related]
32. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
[TBL] [Abstract][Full Text] [Related]
33. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
[TBL] [Abstract][Full Text] [Related]
34. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
35. [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J; Fakra E; Blin O
Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
[TBL] [Abstract][Full Text] [Related]
36. A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder.
Chouinard G; Saxena B; Bélanger MC; Ravindran A; Bakish D; Beauclair L; Morris P; Vasavan Nair NP; Manchanda R; Reesal R; Remick R; O'Neill MC
J Affect Disord; 1999 Jul; 54(1-2):39-48. PubMed ID: 10403145
[TBL] [Abstract][Full Text] [Related]
37. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
[TBL] [Abstract][Full Text] [Related]
38. Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.
Russell JM; Koran LM; Rush J; Hirschfeld RM; Harrison W; Friedman ES; Davis S; Keller M
Depress Anxiety; 2001; 13(1):18-27. PubMed ID: 11233456
[TBL] [Abstract][Full Text] [Related]
39. Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
Bitran S; Farabaugh AH; Ameral VE; LaRocca RA; Clain AJ; Fava M; Mischoulon D
Int Clin Psychopharmacol; 2011 Jul; 26(4):206-12. PubMed ID: 21278577
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
Leombruni P; Pierò A; Lavagnino L; Brustolin A; Campisi S; Fassino S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1599-605. PubMed ID: 18598735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
